ANAB — AnaptysBio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for AnaptysBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	394	548	441	391	385
Net Total Receivables	—	0.876	1.42	6.85	40.8
Prepaid Expenses
Total Current Assets	397	554	447	407	432
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.13	21.8	20	18.3	16.2
Long Term Investments
Other Long Term Assets
Total Assets	417	643	610	452	484
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	19.8	16.1	26.1	37.4	45.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.8	287	348	364	413
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	397	356	262	88.1	70.9
Total Liabilities & Shareholders' Equity	417	643	610	452	484
Total Common Shares Outstanding